Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
Andreas JungAnnalisa OrentiFiona DunlevyElina AleksejevaEgil BakkeheimVladimir BobrovnichySiobhán B CarrCarla ColomboHarriet CorvolRebecca CosgriffGéraldine DaneauDeniz Dogru ErsozPavel DrevinekAndrea Dugac VukicIsabelle FajacAlice FoxStojka FustikVincent GulmansSatenik HarutyunyanElpis HatziagorouIrena KasmiHana KayserováElena KondratyevaUroš KrivecHalyna MakukhKestutis MalakauskasEdward F McKoneMeir Mei-ZahavIsabelle de MonestrolHanne Vebert OlesenRita PadoanTsitsino ParulavaMaria Dolores Pastor-ViveroLuísa PereiraGuergana PetrovaAndreas PflegerLiviu PopJacqui G van RensMilan RodicMarc SchlesserValerie StormsOxana TurcuLukasz Woz NiackiPanayiotis YiallourosAnna ZolinDamian G DowneyLutz NaehrlichPublished in: ERJ open research (2021)
SARS-CoV-2 infection yielded high morbidity and hospitalisation in pwCF. PwCF with forced expiratory volume in 1 s <70% predicted, CFRD and those with lung transplants are at particular risk of more severe outcomes.